Patent · US Active

Amplification-integrated genetic material depletion of non-target organisms using differentially abundant k-mers

US11572593B2 · kind B2 · utility

0Cited by

2References

31Claims

0Family size

Assignee

Siemens Aktiengesellschaft · DE

Inventors

Carsten Dietrich · Nuremberg, DE
Yiwei Huang · Erlangen, DE
Mark Matzas · Heidelberg, DE
Andreas Posch · Wien, AT

Key dates

Filing date	Nov 28, 2017
Grant date	Feb 7, 2023
Priority date	—
Expiry date	Aug 29, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to a method of selectively amplifying at least one nucleic acid sequence of at least one microorganism and/or virus in a sample of a subject, wherein k-mers 3 are applied that show a difference in frequency and/or context in the genome 2 of the at least one microorganism and/or virus compared to the genome of the subject 1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.